Stockscreener 앱 받기
0.32%
전일 마감가:
$198.66
열려 있는:
$199.93
하루 거래량:
236.02K
Relative Volume:
0.27
시가총액:
$12.68B
수익:
$13.84B
순이익/손실:
$1.10B
주가수익비율:
18.98
EPS:
10.4185
순현금흐름:
$1.49B
1주 성능:
-0.85%
1개월 성능:
+29.93%
6개월 성능:
+64.68%
1년 성능:
+42.96%
1일 변동 폭
$197.38
$202.56
1주일 범위
$194.10
$202.56
52주 변동 폭
$101.00
$202.69
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
197.57 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
394.22 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
174.53 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
21.71 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.18 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
DaVita stock (US23918K1088): Q4 2025 revenue beat and debt load stay in focus - AD HOC NEWS
DaVita Honors Extraordinary Nurses With the 2026 DAISY Awards - ACCESS Newswire
DaVita stock (US23918K1088): solid Q1 2025 earnings keep dialysis specialist in focus - AD HOC NEWS
DaVita Inc stock (US23804L1035): earnings, buyback and outlook after strong first quarter - AD HOC NEWS
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
AI shows promise as health systems invest in chronic disease tech - Modern Healthcare
DaVita ESG Roadmap Links 2030 Care Goals To Core Operations - Yahoo Finance
DaVita Inc. Lifts Outlook After Q1 Earnings Beat - TipRanks
DaVita stock (US23918K1088): Insider sale follows strong Q1 2026 earnings - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Best Value Stocks to Buy for May 19th - Yahoo Finance Australia
DaVita stock (US23918K1088): solid Q1 2026, buyback boost and kidney care focus - AD HOC NEWS
Davita chief compliance officer James Hearty sells $2.9m in stock - Investing.com India
DaVita Inc (DVA) Stock Price, Trades & News - GuruFocus
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals - PR Newswire
Zacks.com featured highlights include DaVita, Antero Resources, PBF Energy and Popular - Yahoo Finance Singapore
DaVita stock (US23918K1088): dialysis provider in focus after strong share price run - AD HOC NEWS
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
How Investors Are Reacting To DaVita (DVA) Q1 Earnings Beat And Aggressive Share Buybacks - simplywall.st
DaVita Inc (DVA) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 89/100 - GuruFocus
DaVita stock (US23918K1088): shares stay near 2026 highs after latest pullback - AD HOC NEWS
DaVita Inc. stock (US23918K1088): strong year-to-date rally despite latest pullback in healthcare se - AD HOC NEWS
DaVita Inc (DVA) Stock Up 3.7% but GF Value Says Overvalued -- G - GuruFocus
The 5 Most Interesting Analyst Questions From DaVita’s Q1 Earnings Call - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Does DaVita Insider Equity Move Signal Governance in Russell 1000? - Kalkine Media
DaVita CFO & Treasurer Joel Ackerman Sells 34% Of Holding - simplywall.st
DaVita stock (US23918K1088): TD Cowen raises price target after Q1 earnings - AD HOC NEWS
Insider Sell Alert: David Maughan Sells 20,529 Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita COO David Maughan sells $4.09 million in company stock By Investing.com - Investing.com South Africa
DaVita(DVA.US) Officer Sells US$4.09 Million in Common Stock - Moomoo
What Does DaVita Inc.'s (NYSE:DVA) Share Price Indicate? - 富途牛牛
DaVita stock (US23918K1088): Q1 EPS beat and raised full-year guidance - AD HOC NEWS
What Are Wall Street Analysts' Target Price for DaVita Stock? - Yahoo Finance
DaVita Stock On Fire: Up 32% With 7-Day Winning Streak - Trefis
DaVita Stock Rockets 32% With 7-Day Winning Streak - Trefis
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock - Yahoo Finance
DaVita stock (US23918K1088): TD Cowen raises price target to $201 - AD HOC NEWS
DaVita Stock 6-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: Joel Ackerman Sells 51,471 Shares of DaVita Inc (D - GuruFocus
DaVita (DVA) Leads Goldman Sachs' Buyback Aristocrats Index with Aggressive Share Repurchases - GuruFocus
DaVita HealthCare (DVA) Is Up 30.99% in One Week: What You Should Know - Yahoo Finance
DaVita stock (US23918K1088): Q1 beat and raised guidance lift shares - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Position - DirectorsTalk Interviews
DaVita Inc. stock (US23918K1088): Q1 2026 beat lifts shares after guidance hike - AD HOC NEWS
DaVita Inc. stock (US23918K1088): Q1 2026 earnings and share buybacks lift sentiment - AD HOC NEWS
Evaluating DaVita (DVA) After A Strong Share Price Rally And Mixed Valuation Signals - Yahoo Finance
DaVita Stock 5-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: James Hearty Sells Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.25%
0.58%
자본화:
|
볼륨(24시간):